In one study, intramuscular injection of an antisense oligonucleotide (AON) induced skipping of exon 51 and restored the disrupted open reading frame and, therefore, the production of dystrophin in 4 DMD patients with deletion of exons 48–50, 49–50, 50, and 52, respectively. This evidence concerns the gene DMD and Duchenne muscular dystrophy.